APPLICATION

Just in time when resistant pathogens emerge to cause noscomial infections

Cefixime 200 mg. + Ofloxacin 200 mg. Tablets

Power against noscomical bacteria

Ensured Bioavailability &
Enhanced Spectrum
Ensured Stability &
Enhanced Survival Rates
Ensured Eradication Rates &
Enhanced Clinical Efficacy

Safe & Sure Therapeutic Results In
Respiratory Trct Infections
Gastrointestinal Infections
Urinary Tract Infections
Surgical Prophylaxis
Gynaecological Infections